4 Results for "

DWP14012

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "DWP14012" in MCE Product Catalog:

Cat. No.: HY-109079
CAS No.: 1902954-60-2
Purity:  99.86%
Synonyms: DWP14012; Fexuprazan
Target:  

Proton Pump

Research Areas:  

Metabolic Disease

Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H +, K +- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases .
loading...
    loading...
Cat. No.: HY-109079A
CAS No.: 1902954-87-3
Purity:  99.87%
Synonyms: DWP14012 hydrochloride; Fexuprazan hydrochloride
Target:  

Proton Pump

Research Areas:  

Metabolic Disease

Abeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H +, K +- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan hydrochloride is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases .
loading...
    loading...
Cat. No.: HY-109079AR
CAS No.: 1902954-87-3
Synonyms: DWP14012 hydrochloride (Standard); Fexuprazan hydrochloride (Standard)
Research Areas:  

Metabolic Disease

Abeprazan hydrochloride (Standard) is the analytical standard of Abeprazan (hydrochloride) (HY-109079A). This product is intended for research and analytical applications. Abeprazan hydrochloride (DWP14012 hydrochloride) is a potassium-competitive acid blocker. Abeprazan hydrochloride inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan hydrochloride is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases .
loading...
    loading...
Cat. No.: HY-109079R
CAS No.: 1902954-60-2
Synonyms: DWP14012 (Standard); Fexuprazan (Standard)
Research Areas:  

Metabolic Disease

Abeprazan (Standard) is the analytical standard of Abeprazan (HY-109079). This product is intended for research and analytical applications. Abeprazan (DWP14012) is a potassium-competitive acid blocker. Abeprazan inhibits H+, K+- ATPase by reversible potassium-competitive ionic binding with no acid activation required. Abeprazan is developed as a potential alternative to proton pump inhibitor for the treatment of acid-related diseases .
loading...
    loading...